Want to learn more? Check out our

A Discussion on Dural Venous Sinus Stenosis

Dr. Srinivasan and Dr. Duckwiler share their expertise on venous sinus stenosis and how venous sinus stenting can significantly improve IIH symptoms

On February 6, Doctor Visish Srinivasan explained what dural venous sinus stenosis (VSS) is and how venous sinus stenting can significantly improve papilledema, headache, and and pulsatile tinnitus.

In case you missed it, here are some highlights of his lecture:

  • The road to reach the diagnosis of IIH is a long and convoluted one. It may take several months or years to receive the workup that will aid in diagnosing this neurological condition. Increased awareness of IIH on both the medical and patient side can help reduce the time it takes to navigate through the healthcare system.
  • In one with venous sinus stenosis, MRI and MRV findings may be normal, but is revealed with cerebral angiography.
  • A good candidate for venous sinus stenting is one who has the diagnosis of IIH or pulsatile tinnitus and failing conservative treatment or has unbearable side effects from it, has a venous sinus pressure gradient of greater than 8 mm Hg (diagnosed by venous manometry), and has focal stenosis seen of the venous sinus(es).
  • Complications of venous sinus stenting are: intracranial bleeding (1.9%), requires a repeat endovascular procedure (9%), and cerebrospinal fluid diversion (3%).
  • After review of 474 patients who underwent venous sinus stenting, improvement of papilledema (93.7%), pulsatile tinnitus (90.3%) and headache (79.6%) was appreciated.

Thank you to Dr. Srinivasan and Dr. Duckwiler for your time and expertise on venous sinus stenosis. To watch the full lecture, click here.

If you would like to attend our next lecture, click here.

Related articles

Omar Choudhri, MD
March 7, 2024
Dr. Omar Choudhri discusses the factors that contribute to the pathophysiology of IIH and advanced imaging to help aid in the diagnosis...
December 14, 2023
Dr. Plenty discusses the importance in understanding how these two conditions are interrelated, as over 95% of people affected with IIH are women ...

Stay Informed

Stay up-to-date on the latest research and resources on this Hub by subscribing to our monthly newsletter

Like what you are seeing?

Join our next webinar.

Thank you! You’re registration is complete for:

IIH Community Chat

Discussion on navigating through the healthcare system

April 25 at 10am ET